BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with...
Industry: Biotechnology
Sector: Healthcare
Phone: 604-921-1810
Fax: 604-921-1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada